SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-003927
Filing Date
2024-01-08
Accepted
2024-01-08 08:01:30
Documents
17
Period of Report
2024-01-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d715256d8k.htm   iXBRL 8-K 47310
2 EX-2.1 d715256dex21.htm EX-2.1 501565
3 EX-99.1 d715256dex991.htm EX-99.1 78724
4 EX-99.2 d715256dex992.htm EX-99.2 30691
8 GRAPHIC g715256g0108081612639.jpg GRAPHIC 3999
9 GRAPHIC g715256g0108081612826.jpg GRAPHIC 3507
  Complete submission text file 0001193125-24-003927.txt   957685

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA harp-20240107.xsd EX-101.SCH 2856
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20240107_lab.xml EX-101.LAB 18737
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20240107_pre.xml EX-101.PRE 11711
11 EXTRACTED XBRL INSTANCE DOCUMENT d715256d8k_htm.xml XML 3485
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 24518406
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)